Name | Value |
---|---|
Revenues | 143.5M |
Cost of Revenue | 55.3M |
Gross Profit | 88.2M |
Operating Expense | 60.8M |
Operating I/L | 27.4M |
Other Income/Expense | -0.8M |
Interest Income | 0.0M |
Pretax | 26.7M |
Income Tax Expense | 1.0M |
Net Income/Loss | 25.7M |
TransMedics Group, Inc. is a medical technology company specializing in organ transplant therapy. The company's main revenue source comes from its Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system. OCS replicates near-physiologic conditions for donor organs outside of the human body, offering solutions for lung, heart, and liver transplants. The OCS LUNG preserves standard criteria donor lungs for double-lung transplantation, OCS Heart provides extracorporeal perfusion and preservation of donor hearts, and OCS Liver is designed for the preservation of donor livers.